🇺🇸 FDA
Pipeline program

Prednisone

2023SL049

Phase 2 small_molecule active

Quick answer

Prednisone for Langerhans Cell Histiocytosis of Bone is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Langerhans Cell Histiocytosis of Bone
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials